Home/Filings/4/0001104659-20-022137
4//SEC Filing

Bergstein Ivan 4

Accession 0001104659-20-022137

CIK 0001264587other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 9:28 PM ET

Size

4.9 KB

Accession

0001104659-20-022137

Insider Transaction Report

Form 4
Period: 2020-02-10
Bergstein Ivan
DirectorCEO, Pres., Treas., Sec.10% Owner
Transactions
  • Award

    Common Stock

    2020-02-10+425,2742,940,047 total
Footnotes (2)
  • [F1]The 425,274 restricted shares will vest in three installments as follows: 141,758 shares on March 31, 2021, 141,758 shares on January 19, 2022, and 141,758 shares on April 12, 2023.
  • [F2]Of the shares listed, 1,003,969 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001554767

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:28 PM ET
Size
4.9 KB